These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3132729

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G, Huber G, Schüttler R.
    Psychiatr Clin (Basel); 1980 Jul; 13(3-4):179-92. PubMed ID: 6113621
    [Abstract] [Full Text] [Related]

  • 6. Reducing the dose of depot neuroleptics in stable schizophrenia.
    Dale R, Longdon M, Seeman MV.
    J Psychiatry Neurosci; 1994 Jul; 19(4):278-81. PubMed ID: 7918349
    [Abstract] [Full Text] [Related]

  • 7. Depot neuroleptic therapy: clinical considerations.
    Remington GJ, Adams ME.
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [Abstract] [Full Text] [Related]

  • 8. [Depressive syndromes within the scope of schizophrenic psychoses].
    Hinterhuber H, Neumann R.
    Wien Med Wochenschr; 1985 Sep 30; 135(18):435-41. PubMed ID: 3933187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Long-term clinical experience with clozapine].
    Gelly F, Chambon O, Marie-Cardine M.
    Encephale; 1997 Sep 30; 23(5):385-96. PubMed ID: 9453932
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
    Glazer WM, Ereshefsky L.
    J Clin Psychiatry; 1996 Aug 30; 57(8):337-45. PubMed ID: 8752015
    [Abstract] [Full Text] [Related]

  • 16. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P, Hansen LB, Højholdt K, Larsen NE.
    Acta Psychiatr Scand Suppl; 1985 Aug 30; 322():29-40. PubMed ID: 3907279
    [Abstract] [Full Text] [Related]

  • 17. Risks versus benefits of different types of long-acting injectable antipsychotics.
    McEvoy JP.
    J Clin Psychiatry; 2006 Aug 30; 67 Suppl 5():15-8. PubMed ID: 16822092
    [Abstract] [Full Text] [Related]

  • 18. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA, Aderounmu AF.
    J Clin Psychiatry; 1982 May 30; 43(5):195-6. PubMed ID: 7076630
    [Abstract] [Full Text] [Related]

  • 19. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
    Müller P.
    Nervenarzt; 1983 Sep 30; 54(9):477-85. PubMed ID: 6138720
    [No Abstract] [Full Text] [Related]

  • 20. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 Sep 30; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.